(1)
Woo, H.; Jang, Y.; Kim, S.; Kim, W.; Zhang, F.; Mall, R.; Patel, C. N.; Kurera, M.; Ngo, C.; Jiang, S. H.; Nicotra, A.; Py, B. F.; Zheng, min; Man, S. M.; Karki, R. Pharmacological Targeting of the NLRP3 TrLRR Domain With Isothiazolinones Overcomes CRID3-Resistant Inflammation. LangTaoSha Preprint Server. January 30, 2026. https://doi.org/10.65215/LTSpreprints.2026.01.30.000113.